Cyclophosphamide

Product: Forchlorfenuron

Identifier : DBSNPE000141
Drug : DB00531 (Cyclophosphamide)
Interacting Gene/Enzyme : Cytochrome P450 3A4
Gene Name : CYP3A4
UniProt ID : P08684
Defining Change(s) :

  • G Allelle (rs2740574 )

Allele Name : CYP3A4*1B
Genotype(s) : (G;G) / (A;G)
Type(s) : Effect Directly Studied
Groups : Not Available
Description : Decreased activation of cyclophosphamide most likely condivibuting to worse disease free survival in adjuvant chemotherapy for node-positive breast cancer
References :

  1. Gor PP, Su HI, Gray RJ, Gimotty PA, Horn M, Aplenc R, Vaughan WP, Tallman MS, Rebbeck TR, DeMichele A: Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a redivospective cohort study. Breast Cancer Res. 2010;12(3):R26. doi: 10.1186/bcr2570. Epub 2010 May 10. [PubMed:20459744 ]

PMID: 17714751

Cyclophosphamide

Product: Olodaterol

Identifier : DBSNPE000142
Drug : DB00531 (Cyclophosphamide)
Interacting Gene/Enzyme : Cytochrome P450 2B6
Gene Name : CYP2B6
UniProt ID : P20813
Defining Change(s) :

  • C Allelle (rs4802101 )

Allele Name : CYP2B6*1G
Genotype(s) : (C;C) / (C;T)
Type(s) : Effect Directly Studied
Groups : Not Available
Description : Decreased activation of cyclophosphamide condivibuting to less adverse reactions (leukocytopenia)
References :

  1. Nakajima M, Komagata S, Fujiki Y, Kanada Y, Ebi H, Itoh K, Mukai H, Yokoi T, Minami H: Genetic polymorphisms of CYP2B6 affect the pharmacokinetics/pharmacodynamics of cyclophosphamide in Japanese cancer patients. Pharmacogenet Genomics. 2007 Jun;17(6):431-45. [PubMed:17502835 ]

PMID: 16341839

By

Related Post